NCT04449484 - Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

January 5, 2022

Study Completion Date

January 5, 2022

Conditions

Parkinson's Disease

Interventions

DRUG

MEDI1341

Intravenous infusion over 60 minutes

OTHER

Placebo

Intravenous infusion over 60 minutes

Trial Locations (5)

Research Site, Atlanta

Research Site, Hallandale

Research Site, Farmington Hills

Research Site, Long Beach

Research Site, Spokane